To check the effect of GNC Nitrosurge Whey as cardiac protective vasodilator during workout

A double blind crossover clinical study to study the effect of GNC Nitrosurge Whey as cardiac protective vasodilator during workout - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2025/02/081296

Enrollment

Registered

2025-02-25

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Test Product: GNC NitrosurgeWhey: Dose: 1 Scope pre Exercise/Training Route of Administration: Oral, Duration- 1 Day Control Intervention1: Whey without active: Dose: 1 Scope pre Exerci

Eligibility

Inclusion criteria

Inclusion criteria: 1) Gender: Male or Female 18 to 50 2) Subjects willing to give written informed consent 3) Women of child bearing potential must have a negative urine pregnancy test prior to study entry. 4) Are free of any systemic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events. 5) Are willing to join the exercise program throughout the study duration.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Change in Heart RateTimepoint: At Day 0, Day 2, Day 4	—

Secondary

Measure	Time frame
Change in Respiration Rate, BP, Body Temperature. Timepoint: At Day 0, Day 2, Day 4	—

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org8937015757

Outcome results